Gastric carcinoma in canines and humans, a review

Publication date

2017-09

Authors

Hugen, SanneISNI 0000000492481453
Thomas, Rachel E.ISNI 000000050628390X
German, A J
Burgener, IwanISNI 0000000506342789
Mandigers, P.J.J.ORCID 0000-0003-2547-6673ISNI 0000000393089835

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

taverne

Abstract

Gastric carcinoma (GC) is the most common neoplasm in the stomach of dogs. Although incidence in the general population is reported to be low, breed-specific GC has a high incidence. Median age at presentation ranges from 8 to approximately 10 years. The disease is mostly located in the lesser curvature and antropyloric region of the stomach. Unfortunately, diagnosis is usually made when the disease is at an advanced stage and, therefore, prognosis is poor. Due to similarities in clinical presentation, diagnosis, histology and prognosis, canine GC may serve as a valuable model for human GC. Extensive pedigrees of canine gastric carcinoma cases could reveal insights for human gastric carcinoma. Putative species differences include the role of Helicobacter in pathogenesis, the wide array of genetic data and screening available for humans, and treatment protocols that are available for human GC.

Keywords

clinical pathology, comparative oncology, genetics; pathology, small animal, Taverne, SDG 3 - Good Health and Well-being

Citation

Hugen, S, Thomas, R E, German, A J, Burgener, I A & Mandigers, P J J 2017, 'Gastric carcinoma in canines and humans, a review', Veterinary and Comparative Oncology, vol. 15, no. 3, pp. 692-705. https://doi.org/10.1111/vco.12249